Загрузка...
Nivolumab in combination with ipilimumab for the treatment of melanoma
Melanoma patients develop resistance to most therapies, including chemo- and targeted-therapy drugs. Single-agent therapies are ineffective due to the heterogeneous nature of tumors comprising several subpopulations. Treatment of melanoma with immune-based therapies such as anti-cytotoxic T-lymphocy...
Сохранить в:
| Опубликовано в: : | Expert Rev Anticancer Ther |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4669949/ https://ncbi.nlm.nih.gov/pubmed/26402246 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/14737140.2015.1093418 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|